Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
TGF-β receptor I inhibitor enhances response to enzalutamide in a pre-clinical model of advanced prostate cancer.
Prostate. 2019 Jan;79(1):31-43. doi: 10.1002/pros.23708. Epub 2018 Aug 28.
Prostate. 2019.
PMID: 30155899
Free PMC article.
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D, Anastos H, Kyprianou N.
Begemann D, et al.
Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17.
Int J Urol. 2018.
PMID: 29345000
Review.
Item in Clipboard
Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
Begemann D, Wang Y, Yang W, Kyprianou N.
Begemann D, et al.
Prostate. 2020 Sep;80(12):926-937. doi: 10.1002/pros.24015. Epub 2020 Jun 16.
Prostate. 2020.
PMID: 32542812
Free PMC article.
Item in Clipboard
Aberrant TGF-β Signaling Drives Castration-Resistant Prostate Cancer in a Male Mouse Model of Prostate Tumorigenesis.
Pu H, Begemann DE, Kyprianou N.
Pu H, et al. Among authors: begemann de.
Endocrinology. 2017 Jun 1;158(6):1612-1622. doi: 10.1210/en.2017-00086.
Endocrinology. 2017.
PMID: 28324007
Free PMC article.
Item in Clipboard
Cite
Cite